Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.5 GBX | +3.57% | +20.83% | +23.40% |
04-24 | No record close for FTSE 100; mixed trade in US | AN |
04-24 | No record close for FTSE 100; mixed trade in US | AN |
Business Summary
Sales per Business
GBP in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Product
57.1
%
| 1 | 77.0 % | 1 | 57.1 % | -23.85% |
Pharma Service
32.2
%
| 0 | 16.1 % | 0 | 32.2 % | +105.52% |
Product Service
10.8
%
| 0 | 6.9 % | 0 | 10.8 % | +60.00% |
Sales per region
GBP in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Europe
44.8
%
| 1 | 69.3 % | 0 | 44.8 % | -33.62% |
North America - Rest of World
34.0
%
| 0 | 22.0 % | 0 | 34.0 % | +58.74% |
United Kingdom
21.2
%
| 0 | 8.7 % | 0 | 21.2 % | +151.14% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrew Newland
FOU | Founder | 63 | 31/03/94 |
Ian Griffiths
DFI | Director of Finance/CFO | - | 31/12/94 |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 04/06/23 |
Stefan Peter
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/14 |
Chief Tech/Sci/R&D Officer | - | 31/10/16 | |
Craig Miller
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/16 |
Andrew Holder
IRC | Investor Relations Contact | - | 31/12/20 |
Brett Swansiger
PRN | Corporate Officer/Principal | - | - |
Nicholas Claxton
PRN | Corporate Officer/Principal | - | 31/10/19 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Griffiths
DFI | Director of Finance/CFO | - | 31/12/94 |
Andrew Newland
FOU | Founder | 63 | 31/03/94 |
Brian Howlett
BRD | Director/Board Member | 80 | 06/01/13 |
Jan Groen
CHM | Chairman | 65 | 31/10/18 |
Juliet Thompson
BRD | Director/Board Member | 57 | 04/01/23 |
Joseph Eid
BRD | Director/Board Member | 56 | 18/01/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 260,580,547 | 232,596,523 ( 89.26 %) | 0 | 89.26 % |
Company contact information
ANGLE Plc
The Surrey Research Park 10 Nugent Road
GU2 7AF, Guildford
+44 14 8334 3434
http://www.angleplc.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.40% | 47.04M | |
-12.91% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-7.14% | 716M | |
-18.10% | 682M |
- Stock Market
- Equities
- AGL Stock
- Company ANGLE plc